WO2023126979 - TOPICAL COMPOSITION COMPRISING DULOXETINE OR ITS SALT AND CAPSAICIN
National phase entry:
Publication Number
WO/2023/126979
Publication Date
06.07.2023
International Application No.
PCT/IN2022/051146
International Filing Date
30.12.2022
Title **
[English]
TOPICAL COMPOSITION COMPRISING DULOXETINE OR ITS SALT AND CAPSAICIN
[French]
COMPOSITION TOPIQUE COMPRENANT DE LA DULOXÉTINE OU SON SEL ET DE LA CAPSAÏCINE
Applicants **
DR.REDDY'S LABORATORIES LIMITED
Inventors
SHARMA, Vipin
MANDAPALLI, Praveen Kumar
SETTI, Mogallapalli LV
CHOUDHURY, Anup Avijit
Priority Data
202141062105
31.12.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2129 | |
| EPO | Filing, Examination, Granting | 12068 | |
| Japan | Filing, Examination, Granting | 2183 | |
| South Korea | Filing, Examination, Granting | 2203 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,323
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present specification relates to pharmaceutical composition comprising duloxetine, or pharmaceutically acceptable salts thereof, and capsaicin. The present specification more particulary relates to topical pharmaceutical composition comprising duloxetine, or pharmaceutically acceptable salts thereof, and capsaicin, for the treatment and/or management of neuropathic pain. Methods of preparing such compositions are also provided.[French]
La présente invention concerne une composition pharmaceutique comprenant de la duloxétine, ou des sels pharmaceutiquement acceptables de celle-ci, et de la capsaïcine. La présente invention concerne plus particulièrement une composition pharmaceutique topique comprenant de la duloxétine, ou des sels pharmaceutiquement acceptables de celle-ci, et de la capsaïcine, pour le traitement et/ou la gestion de la douleur neuropathique. L'invention concerne également des procédés de préparation de telles compositions.